BackgroundDespite advances in the treatment of multiple myeloma. a proportion of patients still hardly achieve desired prognosis. Although microtransplant (MST) has proved promising results in treating several hematological malignancies. it has not been studied in multiple myeloma. https://www.ngetikin.com/quick-offer-1-Gallon-Universal-Primer-Pro-Deep-Penetrating-Primer-big-deal/